Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

It was there that a biopsy uncovered the truth: Armando had Stage 4 metastatic urothelial carcinoma (mUC), also known as advanced bladder cancer. Bladder cancer is a serious, challenging disease ...

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: Extended follow-up of a randomized controlled trial and post-treatment immune cell profiling. Nivolumab (NIVO) plus ...

Exclusive liver invasion as prognostic indicator in T3 gallbladder cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a full ...

AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...

“This is the first prospective trial to address the issue of adjuvant CRT in gallbladder cancer,” Atul Sharma ... those who were on other investigational drugs, or had a history of carcinoma within ...

24% of patients received postoperative radiotherapy. LN+: Lymph nodal involvement; NM: Not mentioned; SCC: Squamous cell carcinoma; TCC: Transitional cell carcinoma. † 3-year overall survival.

Background: Adenocarcinoma of the urinary bladder is a rare malignancy. Radical surgery is suggested as the best available treatment for early-stage disease, but there is currently no consensus on ...

A doctor explained why you have unexpected diarrhoea after getting that gallbladder removal surgery. It has to do with the excess bile produced by your liver. Have you or someone close to you ever ...

The gallbladder is a small organ that plays a vital role in digesting the foods you eat. You may need to follow a gallbladder diet if you have gallstones or if your gallbladder is inflamed or infected ...

Objective: To investigate the optimal cut-off value of immunohistochemical marker Ki67 as a prognostic factor to predict the recurrence of non-muscle invasive bladder urothelial carcinoma (NMIBUC).